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The transcriptional regulation of neuroectoderm (NE)
specification is unknown. Here we show that Pax6
is uniformly expressed in early NE cells of human
fetuses and those differentiated from human embry-
onic stem cells (hESCs). This is in contrast to the later
expression of Pax6 in restrictedmouse brain regions.
Knockdown of Pax6 blocks NE specification from
hESCs. Overexpression of either Pax6a or Pax6b,
but not Pax66PD, triggers hESC differentiation.
However, only Pax6a converts hESCs to NE. In
contrast, neither loss nor gain of function of Pax6
affects mouse NE specification. Both Pax6a and
Pax6b bind to pluripotent gene promoters but only
Pax6a binds to NE genes during humanNE specifica-
tion. These findings indicate that Pax6 is a transcrip-
tional determinant of the human NE and suggest
that Pax6a and Pax6b coordinate with each other in
determining the transition from pluripotency to the
NE fate in human by differentially targeting pluripo-
tent and NE genes.
INTRODUCTION
In mammals, the stepwise cell fate transition during early embry-
onic development is orchestrated by sequential activation/inac-
tivation of lineage-determining transcription factors (Yamanaka
et al., 2006). Oct4, Sox2, and Nanog are required for maintaining
pluripotency of the inner cell mass (ICM) or the epiblast in a blas-
tocyst embryo (Avilion et al., 2003; Chambers et al., 2003; Mitsui
et al., 2003; Nichols et al., 1998). Differentiation of the ICM to
extraembryonic tissues is governed by Cdx2 and Gata6, tran-
scription factors that repress pluripotency while inducing genes
of the trophectoderm and extraembryonic endoderm, respec-90 Cell Stem Cell 7, 90–100, July 2, 2010 ª2010 Elsevier Inc.tively (Jedrusik et al., 2008; Koutsourakis et al., 1999; Niwa
et al., 2005). After the formation of extraembryonic tissues, the
pluripotent epiblasts are converted to three germ layers during
gastrulation, but how these processes are regulated remains
unknown.
One of the best-studied processes during gastrulation, neuro-
ectoderm (NE) specification, is at the center of developmental
biology. Studies in lower vertebrates, including frogs and chicks,
indicate that many transcription factors are involved in NE spec-
ification, including zinc finger proteins, Sox family, Otx family,
and helix-loop-helix transcription factors (Mizuseki et al., 1998;
Nakata et al., 1997; Rex et al., 1997; Sheng et al., 2003). To
date, it is unclear which transcription factor is responsible for
the conversion from pluripotent cells to NE in mammals. The
most promising factor is Sox1, because its expression pattern
parallels NE formation in mouse (Bylund et al., 2003; Pevny
et al., 1998). However, Sox1-knockout mice do not exhibit
severe brain deficits, probably because of compensation by
other Sox members (Nishiguchi et al., 1998). Similarly, the tran-
scriptional determinant for human NE specification is unknown.
The failure in identifying mammalian transcriptional determi-
nants underlying NE specification is at least partly due to the
lack of model systems that permit easy genetic manipulation
and direct observation of developmental processes. Embryonic
stem cells (ESCs), derived from the ICM or epiblast, differentiate
to cells/tissues of the three germ layers according to develop-
mental principles (Murry and Keller, 2008; Stern, 2005; Zhang,
2006). When human ESCs (hESCs) are differentiated toward the
neural fate under a chemically defined medium in the absence
ofgrowth factors,NEcells appear aroundday6–8and formneural
tube-like rosettes at day 14 with corresponding gene expression
patterns (Li et al., 2005; Pankratz et al., 2007; Zhang et al., 2001;
Zhang and Zhang, 2010). This differentiation process resembles
in vivo development of the neural plate and neural tube, and it
therefore represents a useful tool for studying the molecular
underpinnings of human NE specification (Zhang, 2006).
During hESC neural differentiation, the initial NE cells do not
express Sox1, the earliest marker of NE in mouse embryos or
Figure 1. Expression of Neural Transcription Factors in Fetuses and
along ESC Differentiation
(A and B)Western blotting shows temporal expression of Pax6 and Sox1 along
human and mouse ESC differentiation. Arrowheads, Pax6a (lower) and Pax6b
(upper).
(C) Pax6 and Sox2, but not Sox1, are expressed in the neural plate of day 18
and day 21 human fetuses, and Sox1 is detected in the brain and neural tube of
day 26 human fetus.
(D) Sox1 and Sox2 are expressed throughout the mouse neural plate and
neural tube from day 8 to 10.5 whereas Pax6 is absent in day 8 embryos but
present in the forebrain and neural tube at day 10.5.
Scale bars represent 100 mm (C) and 50 mm (D).
Bright field images are provided in Figure S1.
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Pax6 Is the Human Neuroectoderm Determinantin NE differentiated from mouse ESCs (mESCs) (Li et al., 2005;
Pankratz et al., 2007; Pevny et al., 1998; Suter et al., 2008;
Ying et al., 2003). Instead, Pax6, a paired box (Pax) transcription
factor expressed in region-specific neural progenitors after
neural tube closure in mouse (Schmahl et al., 1993; Walther
and Gruss, 1991), is uniformly expressed in hESC-derived NE
(Li et al., 2005; Pankratz et al., 2007). These observations raise
an intriguing possibility that Pax6 may play a novel role in human
NE specification. Three isoforms of Pax6 have been identified.
The canonical Pax6a harbors two DNA binding domains, the
paired domain (PD) and homeodomain (HD), and a proline-
serine-threonine (PST)-rich transactivation domain. Pax6b is
a spliced variant of Pax6, which is produced by insertion of 14
amino acids (exon5a) into the PD, thus conferring different
DNA binding specificity (Epstein et al., 1994; Kozmik et al.,
1997; Walther and Gruss, 1991). The third isoform of Pax6
(Pax66PD) lacks the paired domain. Both Pax6a and Pax6b
are expressed in the brain, whereas Pax66PD is identified
only in eye and olfactory bulb (Kim and Lauderdale, 2006).
In rodents, Pax6 is essential for the development of several
organ systems, including eye, pancreas, and cerebrum (Chi
and Epstein, 2002). In the present study, by genetic manipulation
of ESCs, we discovered that Pax6 is necessary and sufficient for
NE specification from human but not mouse ESCs. We also
found that cell lineage specification of ESCs not only requires
repression of pluripotent genes but also depends on induction
of the target lineage genes.
RESULTS
Pax6 Is Uniformly Expressed in Early Human,
but Not Mouse, NE
During mouse development, Pax6 is first detected in neural
progenitors of the developing forebrain at E8.5–E9.5, 1 day after
the formation of Sox1-expressing NE cells within the neural
plate/tube (Bylund et al., 2003; Pevny et al., 1998; Walther and
Gruss, 1991). However, NE cells differentiated from various
hESC lines (H1, H9, H13, HSF1, HSF6) and induced pluripotent
stem cells (iPSCs) under different conditions uniformly express
Pax6 while Sox1 are still negative (Gerrard et al., 2005; Hu
et al., 2010; Li et al., 2005; Pankratz et al., 2007; Wu et al.,
2010; Yao et al., 2006). Importantly, the Pax6-expressing NE
cells can be readily patterned to region-specific, Sox1-express-
ing neural progenitors, which will give rise to various neuronal
subtypes, including dorsal and ventral forebrain, midbrain, spinal
cord, and retinal cells (Li et al., 2005, 2009; Meyer et al., 2009;
Pankratz et al., 2007; Yan et al., 2005; Zhang et al., 2001).
This suggests that the early Pax6-expressing human NE cells
represent a primitive state. We thus hypothesized that Pax6
may play a unique role in NE specification besides regional
patterning in human. Western blotting analysis revealed that
Pax6 was detectable 6 days after hESC differentiation, whereas
Sox1 started to be detected around day 14 (Figure 1A). This was
confirmed by immunostaining, showing that Pax6, but not Sox1,
was expressed in NE cells at day 8 of differentiation from the H1
and H9 hESC lines as well as a human iPSC line (Figure S1A
available online). In contrast, Pax6 was not detected until 2–3
days after Sox1 expression during mouse ESC neural differenti-
ation (Figure 1B), consistent with previous reports (Bylund et al.,2003; Suter et al., 2008). It is also noteworthy that both Pax6a
and Pax6b, but not Pax66PD, were expressed in early human
NE cells, as confirmed by an antibody recognizing the C terminus
of Pax6 (Figures S1B–S1D; Kim and Lauderdale, 2006).
Validation analysis in human fetal tissues (Figure S1E) revealed
that at E18 (Carnegie stage 8–9), when the neural plate begins to
form, Pax6, but not Sox1, was detected in the single-layered NE
cells that were also Sox2 positive (Figure 1C). This expression
pattern was retained at E21 (Carnegie stage 10), in which the
neural plate becomes pseudo-multiple layered. By the time
that forebrain and midbrain have already been clearly demar-
cated at E26 (Carnegie stage 11–12), Pax6 was now restricted
to the forebrain and part of the spinal cord but absent in theCell Stem Cell 7, 90–100, July 2, 2010 ª2010 Elsevier Inc. 91
Figure 2. Knockdown of Pax6 Inhibits Human NE Specification
In Vitro
(A) Western blotting confirms knockdown of Pax6 in hESCs along neural differ-
entiation.
(B andC) Neural differentiation of hESCswith Pax6 knockdown shows a loss of
migrating columnar NE cells and impairment in subsequent formation of NE
aggregates and generation of bIII-tubulin-positive neurons. Scale bars repre-
sent 50 mm. Values are mean ± SEM.**p < 0.01 versus Luc RNAi control.
(D) Microarray analyses show that fewer genes are up- or downregulatedwhen
the Pax6-RNAi hESCs were differentiated toward the neural fate.
(E) Analysis of the 50 most up- and downregulated genes along differentiation
of the control ESCs showed that these genes were less changed in the Pax6
knockdown lines.
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cells (Figure 1C). Our previous study showed that NE cells differ-
entiated from rhesus monkey ESCs also exhibited early Pax6
expression (Pankratz et al., 2007). Consistent with the in vitro
observations, NE cells of rhesus monkey fetuses uniformly
expressed Pax6, but not Sox1 (Figure S1F). In contrast to
primates, Sox1 and Sox2 were highly expressed in the mouse
neural plate at E8 whereas Pax6 was not expressed (Figure 1D).
At E10.5, Pax6 was expressed in the dorsal forebrain and spinal
cord, but not in the midbrain, whereas Sox1 and Sox2 were
ubiquitously expressed in all NE cells (Figure 1D). Thus, Pax6
is expressed by early human but not mouse NE cells, suggesting
a potential distinct role of Pax6 in human NE specification.
Pax6 Is Required for NE Specification from hESCs
We then built ESC lines that constitutively express RNAi for Pax6
(targeting the homeodomain sequence and thus all three iso-
forms) or luciferase (Luc, as a control) through lentiviral infection
(Figure S2A), and the knockdown efficacy was confirmed by
western blotting (Figure 2A) and RT-PCR (Figures 7A and 7B).
After 10 days of neural differentiation under our chemically
defined conditions, hESC-derived NE cells with Luc RNAi pre-
sented typical columnar NE morphology and organized into
rosettes (Figure 2C; Pankratz et al., 2007; Zhang et al., 2001).
Noticeably, differentiating hESCs with Pax6 RNAi remained as
round aggregates formed by round cells but not migrating
columnar cells (Figure 2C). Consistent results were obtained
with different lines (with or without GFP; Figure S2A) and different
batches of differentiation, indicating that the knockdown pheno-
type was not due to asynchronized differentiation or different
viral integration.
The lack of columnar NE cells after Pax6 knockdown indicates
failure of NE differentiation. Microarray analyses, by means of
mRNA pooled from different transgenic lines, showed that about
500 genes were up- or downregulated more than 5-fold in the
Luc RNAi control line after 6 days of differentiation (Figure 2D).
Consistent with our previous report (Pankratz et al., 2007), the
downregulated genes were related to ESC/epiblast (e.g., Oct4,
Nanog, and Myc) and the upregulated genes (Lhx2, Six3, Six6,
Lmo3, Meis2, N-cadherin, FGF8, FGF9, Delta like 1 homolog,
and Wnt5b) were associated with the early NE (Tables S1 and
S2). In contrast, fewer genes were up- or downregulated in the
Pax6 knockdown cells no matter what threshold (fold change)
was set (Figure 2D). The 50 most up- and downregulated genes
during differentiation of the control ESCs were less changed in
the Pax6 knockdown lines (Figure 2E), which were confirmed
by qRT-PCR (Figure 7B). Thus, cells with Pax6 knockdown
largely retained pluripotent gene expression and had much
less NE gene expression. Cell cycle analyses revealed no differ-
ential cell death or proliferation after Pax6 knockdown (Figures
S6A–S6C). Therefore, Pax6 knockdown prevents hESCs from
differentiation, thus trapping them in the pluripotent state.
After another 1–2 weeks of differentiation, NE cells from the
Luc RNAi group readily formed NE aggregates and generated
bIII-tubulin-positive neurons. In contrast, cells with Pax6 knock-
down under the same conditions rarely formed NE spheres and
they failed to differentiate into neurons in adherent culture
(Figures 2B and 2C). These data also suggest that cells derived
fromPax6RNAi lines are not properly developed to the NE stage.92 Cell Stem Cell 7, 90–100, July 2, 2010 ª2010 Elsevier Inc.To exclude the possibility that the requirement of Pax6 in
NE specification was due to our differentiation protocol, we
adopted a new neural differentiation protocol through dual
SMAD signaling inhibition (Chambers et al., 2009). Again, knock-
down of Pax6 severely blocked pluripotent gene downregulation
and NE gene upregulation even with the addition of BMP inhibi-
tors (Figure S2B). To further exclude the possibility of cell culture
artifact, undifferentiated hESCs were injected subcutaneously
into severe combined immunodeficient (SCID) mice to produce
teratomas, an in vivo system allowing ESC to differentiate into
multilineages including neural tissues. Teratoma generation
efficiency and size were comparable in both control and Pax6
knockdown groups. NE rosettes, revealed by hematoxylin and
Figure 3. Knockdown of Pax6 Inhibits Human Neural Induction
In Vivo
(A and B) Pax6 RNAi hESC-generated teratomas possess far fewer neural
rosettes, confirmed by Sox1 and Sox2 staining, as compared to the luciferase
RNAi lines. Values are mean ± SEM. **p < 0.01 (t test) versus Luc RNAi. Scale
bar represents 100 mm.
(C) Teratomas from Pax6 RNAi lines express much lower amount of Sox1 and
Sox2 proteins (28.3% ± 12.2% for Sox1 and 18.4% ± 5.8% for Sox2) but
a similar level of a-fetoprotein and cytokeratin as compared to the luciferase
RNAi lines.
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and Sox2, were frequently observed in teratomas formed by
hESCs with Luc RNAi but rarely in the Pax6 RNAi group (Figures
3A and 3B). Nevertheless, mesoderm (cartilage) and endoderm
(gut epithelium) derivatives were observed in both Luc and
Pax6 knockdown tumors (Figure 3A). Western blotting analyses
of individual teratomas validated that the levels of neural
transcription factors Sox1 and Sox2 drastically decreased in
the Pax6 knockdown tumors, whereas the endodermal marker,
alpha-fetoprotein (AFP), and epidermal marker, cytokeratin,
were expressed at similar levels in both groups (Figure 3C).
These data indicate that the requirement of Pax6 for human NE
specification is not a culture artifact and Pax6 is probably a
potential downstream factor of extracellular neural inducers
during human NE specification.
Pax6 Is Not Required for Mouse NE Specification
The opposite temporal expression pattern of Pax6 and Sox1 in
human versus mouse suggests a differential role of Pax6 in NE
specification in these two species. To test this hypothesis, we
infected the D3 and Sox1/GFP reporter (Ying et al., 2003) mESCs
with Pax6 or Luc RNAi lentiviruses (the RNAi targeting sequence
is identical between human and mouse) and confirmed the
knockdown efficiency by western blotting (Figure S2E). Differen-
tiation to Sox1-expressing mouse NE cells, indicated by GFP,
was readily observable at day 6 and reached a peak at
day 9–10, consistent with western blotting analyses (Figure 1B).
However, knockdown of Pax6 did not affect the Sox1 level as
evaluated by fluorescent microscopy or FACS, suggesting that
Pax6 is not necessary for mouse NE specification (Figures S2C
and S2D). Western blotting with the naive mESCs (D3 line)
confirmed that neither Pax6 nor Luc RNAi altered the expression
of Sox1 (Figure S2E). The Pax6 RNAi-expressing mouse NE cells
further differentiated to neurons with similar efficiency as the Luc
RNAi control (Figure S2F). The side-by-side comparison of Pax6
RNAi effects on human versus mouse ESC neural differentiation
strongly suggests that Pax6 is a crucial transcription factor for
NE specification in human, but not mouse.
Overexpression of Pax6 in hESCs Downregulates
Pluripotent Gene Expression
We next expressed Pax6a and Pax6b (with GFP fusion to the C
terminus) in hESCs under the elongation factor (EF) 1a promoter
through lentiviral infection (Figure S1B). GFP expression was
visible 30–40 hr after viral infection in both GFP- and Pax6-
GFP-overexpressing cells with the highest GFP expression at
day 4–5. Three days after infection, forced expression of GFP
alone had no effect on Oct4 or Nanog expression, whereas
overexpression of either Pax6a-GFP or Pax6b-GFP resulted in
loss of Oct4 andNanog expression even under the culture condi-
tions that favored ESC maintenance (Figures 4A and 4B).
Overexpression of Pax66PD, however, did not affect Oct4 or
Nanog expression (Figure S3), indicating the requirement of
the paired domain in downregulating pluripotent genes. Further
experiments with Pax6 mutants indicated that deletion of the
N-terminal PAI domain or the PST transactivation domain, but
not the HD of Pax6, abrogated the effect of Pax6 in repressing
Oct4 and Nanog (Figure S3). Therefore, except for the HD, all
of the major parts of the Pax6 molecule, including the paireddomain and the PST domain, are required for the effect of
Pax6 on hESC differentiation.
Overexpression of Pax6a but Not Pax6b Directs hESCs
to NE
Although both Pax6a and Pax6b downregulated pluripotent
genes, it was not known whether the two Pax6 isoforms acted
similarly on NE specification. By monitoring the hESC cultures
daily, we discovered that unlike the GFP control cells, the initially
scattered Pax6a-GFP cells gradually aggregated in the hESC
colonies (Figure 4C). Similar aggregation was observed in
Pax6a6HD mutant (Figure S3). 8 days after lentiviral infection,
Pax6a-positive cells exhibited an elongated columnar morphol-
ogy and formed rosettes (Figure 4D), indicative of their neural
identity. Interestingly, we found that Pax6b-GFP-expressing
cells migrated to the edge of the hESC colonies and eventually
they became large flat cells, giving a membranous appearance
outside of the hESC colonies (Figures 4C and 4D). By fluorescent
microscopy, we noticed kidney-like or horseshoe-shape large
nuclei with two or more lobes in most Pax6b-GFP-positive cells
(Figure 4D). The migration property, cell morphology, and multi-
ploid nuclei suggest that the Pax6b-expressing cells have adop-
ted a trophoblast-like fate.
Although forced expression of Pax6a downregulated Oct4 and
Nanog quickly, expression of another pluripotent factor, Sox2
(also a NE transcription factor), was retained (Figure 5A). The
Pax6a-overexpressing cells also expressed fatty acid binding
protein 7 (Fabp7) and N-cadherin (Figures 5B and 5C), which
are specifically expressed in NE cells. It should be noted thatCell Stem Cell 7, 90–100, July 2, 2010 ª2010 Elsevier Inc. 93
Figure 4. Overexpression of Pax6a or Pax6b
Results in Differentiation to NE and Tro-
phectoderm, Respectively
(A and B) Overexpression of Pax6a or Pax6b in
hESCs for 3 days causes Oct4 and Nanog down-
regulation.
(C) 5 days after lentiviral infection, Pax6+/Oct4
cells start to aggregate. Pax6b cells are present
primarily outside of the hESC colony.
(D) 8 days after infection, Pax6a+ cells form
columnar NE and organize into rosettes whereas
Pax6b+ cells stay outside of the hESC colony
and possess kidney- or horseshoe-shape nuclei.
Insets show the different nuclear morphology of
Pax6a+ and Pax6b+ cells.
Scale bars represent 50 mm.
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Pax6a-expressing cells. We have previously shown that the
primitive NE cells express N-cadherin evenly on the cell
membrane whereas regional neural progenitors that express
Sox1 and are polarized express N-cadherin on the lumen side
(Pankratz et al., 2007). Hence, the specific expression pattern
of N-cadherin in Pax6a-overexpressing cells indicates their
primitive NE state, which coincides with our finding that most
Pax6a-positive cells were negative for Sox1 (Figure 5D). Occa-
sionally, Sox1 was found in the Pax6a-positive cells. Interest-
ingly, the Sox1-expressing cells always had lower Pax6a
expression (Figure 5D). In contrast to Pax6a, Pax6b-overex-
pressing cells showed no expression of any neural marker
tested, confirming their nonneural identity. Furthermore, both
Pax6a and Pax6b cells lacked expression of Brachyury and
AFP, mesodermal and endodermal markers, respectively, or
Gata6, an extraembryonic endodermal maker (data not shown).
Thus, although both Pax6a and Pax6b triggered hESC differen-
tiation through downregulation of pluripotent genes, only Pax6a
directed the cells to a neural fate.
In contrast to the results seen with hESCs, overexpression of
either Pax6a or Pax6b in mESCs neither changed the ESC
morphology nor induced the formation of neural rosettes. Over-
expression of Pax6a or Pax6b in mESCs did not decrease Oct4
expression and the mESCs could be passaged continuously as94 Cell Stem Cell 7, 90–100, July 2, 2010 ª2010 Elsevier Inc.normal ESCs (Figures S4A and S4B).
Therefore, the prominent ESC-differenti-
ation and neural-inducing effects of Pax6
are unique to human ESCs.
Pax6a but Not Pax6b Induces NE
Gene Expression
Expression of either Pax6a or Pax6b dif-
ferentiates hESCs rapidly and this pre-
vented us from establishing stable trans-
genic lines for biochemical studies. We
therefore built inducible Pax6a, Pax6a-
GFP, Pax6b-GFP, and GFP clonal hESC
lines by using a lentivirus-based inducible
system (Xia et al., 2008). As shown by the
inducible GFP line, doxycycline treatment
or induction of GFP expression did notalter themorphology and growth of hESCs. In contrast, induction
of Pax6a-GFP expression in hESCs for 3–4 days trigged neural
rosette formation in the ESC colony (Movies S1 and S2). We
again found that Pax6b-GFP-overexpressing cells tended to
localize in the periphery of the colony and they possessed the
same kidney-like or horseshoe-shape nuclei as seen previously
(data not shown). These results confirmed the observations
made with constitutive Pax6-expressing cells that Pax6a, but
not Pax6b, promotes NE specification.
To examine the dynamics of Pax6 effects, we performed qRT-
PCR analyses after Pax6 was induced for 1, 3, or 5 days in ESC
culture conditions. Consistent with microarray data (Figure 2E;
Table S1), neural differentiation of normal hESCs was accompa-
nied by upregulation of neural transcription factors including
Lhx2, Six3, Six6, Lmo3, and Meis2 as well as neural-related
signaling molecules, such as Fabp7, Lix1, Dlk1, Dach1, and
N-cadherin at days 6 and 10 (Figure 6A). Induction of GFP
expression did not alter the gene expression pattern in hESCs
(Figure 6B). Pax6a or Pax6a-GFP expression greatly induced
those neural genes within 1–3 days, but not genes of extraem-
bryonic lineages, mesoderm, endoderm, or epidermal tissues
(Figure 6B). These results suggest that Pax6a induces neural
gene expression and the fusion of GFP to Pax6 does not interfere
with its function. In animal studies, Pax6 is important for eye and
pancreas development and brain patterning. RT-PCR analysis
Figure 5. Overexpression of Pax6a Induces
Neural Genes
(A) Overexpression of Pax6a, but not Pax6b, in
hESCs maintains Sox2 expression.
(B and C) Pax6a-positive cells express pan neural
markers, Fabp7, and N-cadherin.
(D) Most Pax6a-overexpressing cells do not
express Sox1. However, some cells with a lower
Pax6a level (weaker GFP) are positive for Sox1
(arrows).
Scale bars represent 50 mm.
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(Brachyury), and pancreatic (Sox17, Hnf1b, and Pdx1) genes
or regional patterning genes (FoxG1, En1, Hoxb4, and Nkx2.1)
were not induced by Pax6a (Figures S5A–S5C), further sup-
porting the NE specification effect of Pax6a. In contrast, overex-
pression of Pax6b-GFP did not induce NE gene expression
or characteristic genes from other germ layers except Cdx2
(Figure 6B), a key factor for trophectoderm development. In
this case, Cdx2 was not increased until 5 days after induction
of Pax6b.
It is noteworthy that the NE-inducing effect of Pax6a is quick
and robust. Even in the presence of Activin A and Bio (a GSK3b
inhibitor), a condition that favors mesoendoderm differentiation
(Kroonet al., 2008), Pax6aoverexpression inducedneural rosette
formation within hESC colonies (Figure S5D) with concomitant
elevated expression of NE genes and repressed mesoendoder-
mal transcripts (Figures S5E and S5F). These data suggest that
Pax6 is an intrinsic regulator of human NE specification.
Pax6a and Pax6b Coordinate with Each Other to Specify
the NE Fate
Because both Pax6a and Pax6b were expressed during hESC
NE differentiation (Figures 1A and 7A) but overexpression of
Pax6a alone was sufficient to convert hESCs to NE, we asked
whether Pax6b was needed for NE specification. We selected
one RNAi sequence targeting exon5a that can specifically knock
down Pax6b (Figure 7A; Figure S2A). qRT-PCR showed that
similar to knock down of both isoforms, specific knockdown ofCell Stem Cell 7, 9Pax6b reduced pluripotent gene downre-
gulation and neural gene upregulation
during normal NE differentiation, although
at a modest level (Figure 7B). These re-
sults suggest that Pax6b is also required
for human NE specification. Because
overexpression of Pax6b cannot induce
neural genes, this result suggests that
the way Pax6b functions in human NE
specification is through coordinating
with Pax6a in downregulation of pluripo-
tent genes, which is a prerequisite for
subsequent upregulation of neural genes.
In addition, the neural blocking effect
was reproduced with two Pax6 RNAi
constructs, ensuring that the phenotype
was due to knock down of Pax6, but not
off-target effects.We then asked whether Pax6 can regulate lineage genes
directly. Pax6a-GFP, Pax6b-GFP, and GFP lines were induced
with doxycycline for 1 and 3 days, and chromatin immunoprecip-
itation (ChIP) analysis was performed to examine the binding of
Pax6 to promoters of lineage-specific genes. GFP protein did
not show any binding to the pluripotent genes or neural genes
(data not shown). Both Pax6a and Pax6b were found to localize
to theOct4 andNanog promoters (Figure 7C). Pax6 bound to the
Nanog promoter 1 day after Pax6 was induced, earlier than it
bound to theOct4 promoter. This is consistent with the observa-
tion that Nanogwas downregulated earlier thanOct4 in normally
differentiated cells (Figure 7B). As expected, only Pax6a bound
to the promoters of neural genes that were upregulated after
Pax6a expression, mostly at day 3 (Figure 7C). In summary,
both Pax6a and Pax6b bound to the promoters of pluripotent
genes, corresponding to the downregulation ofOct4 andNanog.
Pax6a, but not Pax6b, occupied the promoters of neural genes,
coinciding with the NE fate mediated by Pax6a.
DISCUSSION
Since the groundbreaking work by Spemann and Mangold,
signaling pathways that lead to NE induction, including BMP
inhibition and FGF activation, are now well established (Levine
andBrivanlou, 2007;Mun˜oz-Sanjua´n andBrivanlou, 2002; Stern,
2005, 2006). However, transcriptional networks that control NE
specification are not well defined. Our present study provides
evidence that Pax6 is both necessary and sufficient for NE0–100, July 2, 2010 ª2010 Elsevier Inc. 95
Figure 6. Overexpression of Pax6a Converts
hESCs to the Neural Fate in Inducible Lines
(A) Native hESCs were differentiated for 4, 6, and 10 days
to the neural lineage and gene expression was analyzed
by qRT-PCR. Pax6 along with other NE genes are signifi-
cantly transcribed during differentiation. In contrast, extra-
embryonic markers Cdx2 and Gata6; epidermal markers
K18 and Lama3; and mesodermal and endodermal
markers Brachyury and Sox17 are not expressed when
the cells are differentiated to NE.
(B) Induction of GFP or Pax6b-GFP expression does not
alter the expression of any of the neural genes. Expression
of Pax6a or Pax6a-GFP in hESCs causes expression of
neural-specific genes, but not other lineage markers.
The trophectoderm marker Cdx2 is slightly transcribed
but only after 5 days of Pax6b induction.
Values are mean ± SEM.
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raises a question of how such a well-conserved protein acquired
the novel function in human brain development over evolution.
Furthermore, we discovered that the neural inductive function
of Pax6 is achieved by its repression of pluripotent genes and
activation of NE genes. Taken together with the unique differen-
tial effects of Pax6a and Pax6b, we propose that specification of
epiblast or ESCs to an embryonic germ layer depends upon
induction of the target germ layer genes and repression of
pluripotent genes and possibly also genes of other germ layers
(Figure 7D). This proposition opens the possibility for the exis-
tence of a determinant gene(s) for mesoderm and endoderm.96 Cell Stem Cell 7, 90–100, July 2, 2010 ª2010 Elsevier Inc.Pax6 Is Necessary and Sufficient
for Human NE Specification
In this study, we have demonstrated that
overexpression of Pax6, either constitutively
or conditionally, converts hESCs to NE, even
under conditions that favor hESC maintenance
or mesoendoderm differentiation. The NE iden-
tity was verified by the characteristic columnar
cells that organize into rosettes, loss of pluripo-
tent gene expression, upregulation of NE genes,
and lack of other germ layer markers. Knock-
down of Pax6 blocks NE specification from
hESCs not only in the teratoma assay, which
allows spontaneous three-germ-layer differenti-
ation in vivo, but also in our chemically defined
NE differentiation system and a newly devel-
oped dual SMAD inhibition culture, both of
which strongly promote hESC neural differentia-
tion. These results, gathered from both gain of
function and loss of function of Pax6 under
opposing conditions, strongly indicate that
Pax6 is an intrinsic determinant for the human
NE fate. The fact that overexpression of Pax6
does not induce mesoendoderm and that
knockdown of Pax6 does not inhibit mesoendo-
dermal lineage differentiation excludes the
possibility that Pax6 first promotes mesoendo-
dermal differentiation which in turn induces
neural differentiation. This is further supportedby the result that dual SMAD inhibition by Noggin and
SB431542 does not rescue the neural blocking effect when
Pax6 is knocked down. Therefore, Pax6 is most probably
a crucial downstream effector of neural inducers, such as BMP
inhibitors.
Pax6-Mediated NE Specification Depends on Both
Repression of Pluripotent Genes and Induction of NE
Genes
It is quite remarkable that a single transcription factor, Pax6, can
act as a switch from proliferating hESCs to differentiating NE.
This is a direct cell fate conversion rather than an indirect
Figure 7. Pax6a and Pax6b Coordinate with Each
Other in Switching Pluripotent Cells to the NE Fate
(A) Pax6b RNAi downregulates Pax6b specifically in
hESCs during neural differentiation.
(B) Knockdown of Pax6b diminishes the downregulation of
pluripotent genes and upregulation of neural genes in
a similar pattern to knockdown of both Pax6a and Pax6b.
(C) Both Pax6a and Pax6b can be recruited to the
promoters of pluripotent genes, but only Pax6a binds to
the promoters of neural genes. *p < 0.05; **p < 0.01 versus
day 0.
(D) A model for Pax6 in neural specification from hESCs.
Both Pax6a and Pax6b bind to the promoter of pluripotent
genes (e.g., Oct4 and Nanog), repress the expression of
pluripotent genes, and drive the cells out of the ESC state.
However, loss of stem cell state does not automatically
confer neural differentiation. Specification of the NE fate
is dependent upon the neural inductive effect of Pax6a,
which binds to a set of neural gene promoters and induces
their expression.
Values are mean ± SEM.
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ing NE in the hESCs (Schroeder, 2008). First, hESCs, maintained
under standard culture conditions, do not express Pax6, an early
marker of human NE cells now widely used. Second, overex-
pression or knockdown of Pax6 does not alter cell proliferation
or survival (Figure S6). Third, time-lapse tracking reveals that
once Pax6 is turned on, the cells become columnar NE, migrate,
and aggregate to form rosettes (Movies S1 and S2). Further-
more, at the molecular level, Pax6 binds to pluripotent genes
and NE genes directly.
Both Pax6a andPax6b bind to promoters of pluriptoent genes,
includingOct4 andNanog, and repress their expression whereas
only Pax6a binds to NE gene promoters and activates NE genes.
Therefore, the NE fate-determining role of Pax6 is achieved
through coordination of Pax6a and Pax6b in preventing hESC
self-renewal, thus initiating their differentiation and inducingCell Stem Cthe cells toward the NE fate by Pax6a. Suppres-
sion of pluripotent factors alone is not sufficient
for differentiating ESC/epiblast to NE. This is
demonstrated by the fact that overexpression
of Pax6b, which does not possess neural-
inducing activity, drives hESCs out of the stem
cell state but these cells turn into trophoblast.
This phenomenon is reminiscent of the extraem-
bryonic outcome of ESCs with knockdown of
Oct4, Nanog, or Sox2 (Chew et al., 2005; Fong
et al., 2008; Hay et al., 2004; Hyslop et al.,
2005; Matin et al., 2004; Zaehres et al., 2005).
Thus, repression of pluripotent genes initiates
the differentiation process but it alone is not
sufficient for embryonic germ layer differentia-
tion. Pax6a is probably the key inductive signal
for the NE fate. Indeed, Pax6a binds to a set of
downstream neural genes, which corresponds
to the neural phenotypes. Pax6b, though by
itself not a direct neural inducer, potentiates
the neural inductive effect of Pax6a through
collaboration with Pax6a for sufficient repres-sion of pluripotent genes, which is a prerequisite for induction
of neural genes (Figure 7D).
The NE Specification Role of Pax6 Is Unique to Primates
The Pax6 protein is highly conserved. It plays critical roles in the
development of eyes and pancreas and patterning of neural
progenitors across species (Chi and Epstein, 2002). Indeed,
the expression pattern of Pax6 in the developing human nervous
system (after brain regions are formed) is very similar to that in
other model systems, including mouse, frog, chick, and fish
(Amirthalingam et al., 1995; Goulding et al., 1993; Schlosser
and Ahrens, 2004; Walther and Gruss, 1991). We have also
confirmed that Pax6 is essential for patterning human NE cells
to ventral spinal progenitors and dorsal telencephalic progeni-
tors (Li et al., 2005, 2009). Our side-by-side comparison of
Pax6 expression and function between mouse and humanell 7, 90–100, July 2, 2010 ª2010 Elsevier Inc. 97
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specification. Considering the similar expression pattern of Pax6
in early rhesusmonkey fetuses, this NE specification role of Pax6
probably is unique to primates. This finding raises a question as
to why the classical transcription factor, with 100% amino acid
sequence homology between mouse and human, acquires
a new role in human brain development. The brain, especially
the forebrain, is the most highly evolved structure in either size
or complexity among species (Dorus et al., 2004; Kaas, 2006;
Rakic, 2009). Corresponding to the increasing size of the fore-
brain, some neural transcription factors, especially anterior tran-
scription factors Sox2 and Otx2 whose expression is restricted
to the neural lineage in lower vertebrates, are now found at earlier
developmental stages in mammals, even in the inner cell mass
and the epiblast of the embryo (Avilion et al., 2003; Simeone
et al., 1993). The cerebrum in primates, especially in human, is
proportionally larger and more complex in neural circuitry than
in rodents (Dorus et al., 2004; Kaas, 2006; Rakic, 2009). We
and others have also found that under similar culture conditions
without exogenous morphogens, hESC-derived NE cells tend to
generate cortical glutamatergic neurons whereas mouse NE are
inclined to generate ventral GABAergic neurons (Gaspard et al.,
2008; Li et al., 2009). We speculate that early Pax6 expression
might be the first step to ensure a large cerebrum in primates.
Further studies to identify target genes of Pax6 during NE
specification may well shed light on the evolutionary complex-
ities of our human brain. Our finding also raises the question of
what would be the determinant gene for the NE fate in mouse
or other animals. Comparison of our gene profiles with available
database of mouse NE (Aiba et al., 2006) revealed profound
differences in gene expression between human and mouse
NE, some of which are presented in Figure S1G. While this
comparison corroborates our present finding, it indicates a
need of uncovering the long-sought NE determinant in animals.
EXPERIMENTAL PROCEDURES
Culture and Maintenance of Mouse and Human ESCs
Human ESCs (H9 and H1 lines, passages 18–35) were provided by the WiCell
Institute and were cultured on irradiated mouse embryonic fibroblasts (MEFs)
as previously described (Zhang et al., 2001; Zhang and Zhang, 2010). Human
iPSCs were generated from skin fibroblasts by overexpressing Oct4, Sox2,
Klf4, and c-Myc through retroviral infection (Hu et al., 2010). The standard
protocol can be found at http://www.wicell.org.
Mouse ESCs (D3 line and Sox1/GFP reporter line 46C) were cultured on
MEF supplemented with 50% medium conditioned by Buffalo rat liver cells
(BRL-CM).
Neural Differentiation from Human and Mouse ESCs
Neural differentiation of hESCs was performed according to a published
protocol (Zhang et al., 2001; Zhang and Zhang, 2010). For mESC neural differ-
entiation, half a million cells were suspended in DMEM-F12/neurobasal
medium (1:1 DMEM-F12/neurobasal medium, 13 N2 neural supplement,
13 lipid concentrate, 1 mM L-glutamine, 0.1 mM b-mercaptoethanol, and
40 mg/ml N-acetyl cysteine). For the first 2 days, 2 ng/ml of LIF was supplied.
After another 7 days of culture in suspension without LIF, neruoepithelial
aggregates were dissociated and plated in the same way as for human ESCs.
Tissue Collection
The human fetal tissues used in this study were from patients requesting termi-
nation of pregnancy. All the procedures were approved by the institutional
review board (Ethics Committee) of FudanUniversity ShanghaiMedical School98 Cell Stem Cell 7, 90–100, July 2, 2010 ª2010 Elsevier Inc.and the Shanghai Institute of Biological Sciences, Chinese Academy of
Science, Shanghai and with the informed consent of the patients. Fetal tissues
were obtained within 4 hr after abortion and the developmental stages of fetus
specimens were identified according to the anatomy established by Carnegie
Institute in Washington, USA. Fetal monkey tissues were obtained from
animals at theWisconsin National Primate Research Center in early pregnancy
as previously described (Bondarenko et al., 2007). The tissues were cut into
15–20 mm frozen sections for immunostaining.
Generation and Analysis of Teratomas
Human ESCs were injected subcutaneously into the backs of severe
combined immunodeficient (SCID) mice (Jackson Laboratory) (Xia et al.,
2008). All animal experiments were performed according to the protocols
approved by the Institutional Animal Care and Use Committee, University of
Wisconsin.
Statistical Analyses
Data are presented as mean ± SEM. Student’s t tests were used for statistical
analysis. p < 0.05 was considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, twomovies, and two tables and can be foundwith this article online
at doi:10.1016/j.stem.2010.04.017.
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